Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON37359
NL-OMON37359
Recruiting
Not Applicable

The patient perspective on remission in rheumatoid arthritis - The patient perspective on remission in rheumatoid arthritis

Vrije Universiteit Medisch Centrum0 sites24 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsarthritisRA10003816

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
arthritis
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
24
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •patients with:
  • •\- confirmed diagnosis of RA (1987 criteria)
  • •\- above 18 years of age
  • •for group 1: fulfilling the ACR/EULAR remission criteria
  • •for group 2: being in self\-perceived remission
  • •for group 3: DAS28\=\>3\.2, with 60% having ever had an experience of remission in the past

Exclusion Criteria

  • •\- patients who do not sufficiently speak the local language
  • •\- patient who do not want to sign the informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Remission in rheumatoid arthritis – assessing withdrawal of disease-modifying antirheumatic drugsRheumatoid arthritis (RA)MedDRA version: 15.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2012-005275-14-NODiakonhjemmet Hospital AS360
Completed
Not Applicable
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abataceptrheumatoid arthritis
JPRN-UMIN000016950Osaka Medical College50
Recruiting
Phase 3
Outcome of Rheumatoid Arthritits patients following adjunct statin therapyHealth Condition 1: null- Diagnosed Rheumatoid Arthritis patients with active disease
CTRI/2014/12/005233Kalinga Institute of Medical Sciences60
Completed
Not Applicable
Retention rate of iguratimod with and without methotrexate in patients with rheumatoid arthritis.
JPRN-UMIN000041767Department of Hematology and Rheumatology, Kindai University School of Medicine106
Recruiting
Not Applicable
Rheumatoid Arthritis Patients rePort Onset Reactivatioarthritisrheumatoid arthritis10023213
NL-OMON30946Erasmus MC, Universitair Medisch Centrum Rotterdam150